Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W F Lems

Showing results (151-160 of 175) with videos related to

Pageof 18
Sort By:
Annals of the Rheumatic Diseases|October 14, 2004
Long term high intensity exercise and damage of small joints in rheumatoid arthritisZ de Jong, M Munneke, A H Zwinderman, et al.
Rheumatology (Oxford, England)|April 11, 2008
Value of serum cartilage oligomeric matrix protein as a prognostic marker of large-joint damage in rheumatoid arthritis--data from the RAPIT studyZ de Jong, M Munneke, V Vilim, et al.
Clinical and Experimental Rheumatology|March 31, 2009
The effect of Helicobacter pylori eradication on C-reactive protein and the lipid profile in patients with rheumatoid arthritis using chronic NSAIDsK S S Steen, W F Lems, I M Visman, et al.
Osteoarthritis and Cartilage|June 1, 2013
Knee joint stabilization therapy in patients with osteoarthritis of the knee: a randomized, controlled trialJ Knoop, J Dekker, M van der Leeden, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|January 19, 2021
Long-term effects on bone mineral density after four years of treatment with two intensive combination strategies, including initially high-dose prednisolone, in early rheumatoid arthritis patients: the COBRA-light trialM J J Lucassen, M M Ter Wee, D den Uyl, et al.
Arthritis and Rheumatism|April 1, 2011
Venous and arterial thromboembolic events in adalimumab-treated patients with antiadalimumab antibodies: a case series and cohort studyL A Korswagen, G M Bartelds, C L M Krieckaert, et al.
Osteoarthritis and Cartilage|August 10, 2010
Treatment with TNF-α inhibitor infliximab might reduce hand osteoarthritis in patients with rheumatoid arthritisM Güler-Yüksel, C F Allaart, I Watt, et al.
Annals of the Rheumatic Diseases|May 1, 2008
Preferential decrease in IgG4 anti-citrullinated protein antibodies during treatment with tumour necrosis factor blocking agents in patients with rheumatoid arthritisW H Bos, G M Bartelds, M Vis, et al.
Annals of the Rheumatic Diseases|April 26, 2007
Bone mineral density in patients with recently diagnosed, active rheumatoid arthritisM Güler-Yüksel, J Bijsterbosch, Y P M Goekoop-Ruiterman, et al.
Annals of the Rheumatic Diseases|July 24, 2007
Changes in bone mineral density in patients with recent onset, active rheumatoid arthritisM Güler-Yüksel, J Bijsterbosch, Y P M Goekoop-Ruiterman, et al.
Pageof 18

Showing results (151-160 of 175) with videos related to

Sort By:
Pageof 18
Annals of the Rheumatic Diseases|October 14, 2004
Long term high intensity exercise and damage of small joints in rheumatoid arthritisZ de Jong, M Munneke, A H Zwinderman, et al.
Rheumatology (Oxford, England)|April 11, 2008
Value of serum cartilage oligomeric matrix protein as a prognostic marker of large-joint damage in rheumatoid arthritis--data from the RAPIT studyZ de Jong, M Munneke, V Vilim, et al.
Clinical and Experimental Rheumatology|March 31, 2009
The effect of Helicobacter pylori eradication on C-reactive protein and the lipid profile in patients with rheumatoid arthritis using chronic NSAIDsK S S Steen, W F Lems, I M Visman, et al.
Osteoarthritis and Cartilage|June 1, 2013
Knee joint stabilization therapy in patients with osteoarthritis of the knee: a randomized, controlled trialJ Knoop, J Dekker, M van der Leeden, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|January 19, 2021
Long-term effects on bone mineral density after four years of treatment with two intensive combination strategies, including initially high-dose prednisolone, in early rheumatoid arthritis patients: the COBRA-light trialM J J Lucassen, M M Ter Wee, D den Uyl, et al.
Arthritis and Rheumatism|April 1, 2011
Venous and arterial thromboembolic events in adalimumab-treated patients with antiadalimumab antibodies: a case series and cohort studyL A Korswagen, G M Bartelds, C L M Krieckaert, et al.
Osteoarthritis and Cartilage|August 10, 2010
Treatment with TNF-α inhibitor infliximab might reduce hand osteoarthritis in patients with rheumatoid arthritisM Güler-Yüksel, C F Allaart, I Watt, et al.
Annals of the Rheumatic Diseases|May 1, 2008
Preferential decrease in IgG4 anti-citrullinated protein antibodies during treatment with tumour necrosis factor blocking agents in patients with rheumatoid arthritisW H Bos, G M Bartelds, M Vis, et al.
Annals of the Rheumatic Diseases|April 26, 2007
Bone mineral density in patients with recently diagnosed, active rheumatoid arthritisM Güler-Yüksel, J Bijsterbosch, Y P M Goekoop-Ruiterman, et al.
Annals of the Rheumatic Diseases|July 24, 2007
Changes in bone mineral density in patients with recent onset, active rheumatoid arthritisM Güler-Yüksel, J Bijsterbosch, Y P M Goekoop-Ruiterman, et al.
Pageof 18